Ophthalmology Search
Ophthalmology Ophthalmology
blepharitis
BLEPHARITIS
Blepharitis is an inflammation process affecting the eyelid margins, eyelash follicles or openings of the anteriorly-placed accessory lacrimal glands and the posteriorly-placed Meibomian glands that causes ocular irritation and redness acutely but usually chronically.
It may have periods of exacerbations and remissions.
It usually occurs in middle-aged adults but can also start in childhood.
Can affect vision by disrupting the surface of the cornea and the bulbar conjunctiva; may influence tear film composition.

Follow Up

  • Follow-up visits are based on the severity of symptoms & signs, current treatment & comorbid factors
  • Includes interval history, visual acuity measurement, external exam, slit-lamp biomicroscopy, & intraocular pressure (IOP) measurement
  • Patients should be re-evaluated w/in a few weeks to determine the response to therapy & assess compliance to the treatment regimen
  • Prompt referral to an ophthalmologist is recommended if any of the following is observed
    • Visual loss
    • Moderate or severe pain
    • Severe or chronic redness
    • Involvement of the cornea
    • Recurrent episodes
    • Lack of response to treatment
Editor's Recommendations
Most Read Articles
Every-2-month cabotegravir + rilpivirine feasible for HIV treatment
Pearl Toh, 5 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Why are there fewer COVID-19 cases in children?
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
Sustained lopinavir use may improve condition of COVID-19 patients
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
13 ways to fight COVID-19
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.